Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Idioma: | |
| Publicado em: |
Zenodo
2025
|
| Acesso em linha: | https://doi.org/10.5281/zenodo.17195367 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Sumário:
- <p dir="ltr">Metastasis is the major cause of death from cancer and metastasis to the lung in breast cancer is difficult to treat and heterogeneous in nature, complicating its management (1-5). We recently utilized whole transcriptome technologies to define the full complement of differentially expressed kinases and phosphatases in HER2+ breast cancer: in the primary tumor, and in metastasis to the CNS (6-8). Here we utilize whole transcriptome technologies (9, 10) to measure total transcription in the lung metastases of humans with breast cancer, integrating this with transcriptome data from a cell culture model of lung metastatic potential. We identify here a therapeutic target based on its differential expression and up-regulation upon metastasis to the lung in humans with breast cancer, GRIK4, as a candidate therapeutic target for the medical management of lung metastasis. </p>